Juno ’s Investigational CAR T Cell Product Candidates JCAR018 and JTCR016 Demonstrate Encouraging Clinical Responses in Patients with B-Cell and Mesothelioma Cancers
US Biosimilars Market Report 2016 - Analysis, Technologies & Forecasts - Key Vendors: Amgen, Celltrion, Eli Lilly - Research and Markets
Genome Editing: $2 Billion Technologies and Global Markets Opportunity by 2020 - Research and Markets
The stocks mentioned in this article be holdings in the managed portfolios of Validea Capital Management, a separate asset management firm founded by Validea.com founder John Reese. Validea Capital Management, which an SEC registered investment advisory firm and a separate company from Validea.com, ...
Which funds generated the greatest dollar returns in 2005?